BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8371142)

  • 1. Prostaglandin E2-induced thermal hyperalgesia and its reversal by morphine in the warm-water tail-withdrawal procedure in rhesus monkeys.
    Negus SS; Butelman ER; Al Y; Woods JH
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1355-63. PubMed ID: 8371142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of morphine and ketorolac on thermal allodynia induced by prostaglandin E2 and bradykinin in rhesus monkeys.
    Negus SS; Butelman ER; Gatch MB; Woods JH
    J Pharmacol Exp Ther; 1995 Aug; 274(2):805-14. PubMed ID: 7636744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinociceptive effects of delta-opioid agonists in Rhesus monkeys: effects on chemically induced thermal hypersensitivity.
    Brandt MR; Furness MS; Mello NK; Rice KC; Negus SS
    J Pharmacol Exp Ther; 2001 Mar; 296(3):939-46. PubMed ID: 11181927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kappa opioids in rhesus monkeys. II. Analysis of the antagonistic actions of quadazocine and beta-funaltrexamine.
    Dykstra LA; Gmerek DE; Winger G; Woods JH
    J Pharmacol Exp Ther; 1987 Aug; 242(2):421-7. PubMed ID: 3302207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the structurally novel opioid 14 alpha, 14' beta-[dithiobis [(2-oxo-2,1-ethanediyl)imino]]bis(7,8-dihydromorphinone) on schedule-controlled behavior and thermal nociception in rhesus monkeys.
    Gatch MB; Negus SS; Mello NK; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1282-9. PubMed ID: 8819513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in hyperalgesia during morphine infusion: effect of gonadectomy and estrogen treatment.
    Juni A; Klein G; Kowalczyk B; Ragnauth A; Kest B
    Neuropharmacology; 2008 Jun; 54(8):1264-70. PubMed ID: 18457849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox.
    Zernig G; Butelman ER; Lewis JW; Walker EA; Woods JH
    J Pharmacol Exp Ther; 1994 Apr; 269(1):57-65. PubMed ID: 8169852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.
    Juni A; Klein G; Kest B
    Brain Res; 2006 Jan; 1070(1):35-44. PubMed ID: 16409995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clocinnamox: a novel, systemically-active, irreversible opioid antagonist.
    Comer SD; Burke TF; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1051-6. PubMed ID: 1326622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of systemically administered dynorphin A(1-17) in rhesus monkeys.
    Butelman ER; Harris TJ; Perez A; Kreek MJ
    J Pharmacol Exp Ther; 1999 Aug; 290(2):678-86. PubMed ID: 10411578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat injury-induced drop of the noxious heat threshold measured with an increasing-temperature water bath: a novel rat thermal hyperalgesia model.
    Bölcskei K; Horváth D; Szolcsányi J; Petho G
    Eur J Pharmacol; 2007 Jun; 564(1-3):80-7. PubMed ID: 17397823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methoclocinnamox: agonist and antagonist effects of a novel long-lasting opioid in rhesus monkeys.
    Butelman ER; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1996 Nov; 279(2):934-8. PubMed ID: 8930202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
    Dunbar SA; Karamian I; Zhang J
    Eur J Pain; 2007 Jan; 11(1):1-6. PubMed ID: 16448827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of heroin and its metabolites on schedule-controlled responding and thermal nociception in rhesus monkeys: sensitivity to antagonism by quadazocine, naltrindole and beta-funaltrexamine.
    Negus SS; Brandt MR; Gatch MB; Mello NK
    Drug Alcohol Depend; 2003 May; 70(1):17-27. PubMed ID: 12681522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
    Sterious SN; Walker EA
    J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of beta-funaltrexamine in normal and morphine-dependent rhesus monkeys: observational studies.
    Gmerek DE; Woods JH
    J Pharmacol Exp Ther; 1985 Nov; 235(2):296-301. PubMed ID: 4057071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local administration of mu or kappa opioid agonists attenuates capsaicin-induced thermal hyperalgesia via peripheral opioid receptors in rats.
    Ko MC; Tuchman JE; Johnson MD; Wiesenauer K; Woods JH
    Psychopharmacology (Berl); 2000 Feb; 148(2):180-5. PubMed ID: 10663433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of peripheral kappa opioid receptors inhibits capsaicin-induced thermal nociception in rhesus monkeys.
    Ko MC; Butelman ER; Woods JH
    J Pharmacol Exp Ther; 1999 Apr; 289(1):378-85. PubMed ID: 10087027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of clonidine, dexmedetomidine and xylazine on thermal antinociception in rhesus monkeys.
    Butelman ER; Woods JH
    J Pharmacol Exp Ther; 1993 Feb; 264(2):762-9. PubMed ID: 8094751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
    Broadbear JH; Sumpter TL; Burke TF; Husbands SM; Lewis JW; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.